— Know what they know.
Not Investment Advice
Also trades as: SIGHT.PA (PAR) · $vol 0M

GSGTF OTC

GenSight Biologics S.A.
1W: -11.1% 1M: -11.1% 3M: -11.1% YTD: -57.9% 1Y: -57.9% 3Y: -97.5% 5Y: -98.9%
$0.08
-0.01 (-11.11%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $13.0M mcap · 169M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$8M -23.3% ▼
5Y CAGR: -29.5%
Total Liabilities
$33M -11.9% ▼
5Y CAGR: -1.4%
Shareholders Equity
-$25M +7.4% ▲
Cash & Investments
$2M -2.0% ▼
5Y CAGR: -42.4%
Total Debt
$13M -32.7% ▼
5Y CAGR: -2.3%
Net Debt
$10M -37.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$44M$11M$2M$2M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$44M$11M$2M$2M$2M
Net Receivables$754K$3M$1K$1K$0
Inventory$4M$8M$0$0$0
Other Current Assets-$415K-$8M$3M$2M$3M
Total Current Assets$53M$23M$7M$5M$5M
Property, Plant & Equip.$3M$2M$2M$933K$427K
Goodwill & Intangibles$112K$93K$75K$57K$0
Long-Term Investments$0$633K$0$0$3M
Other Non-Current Assets$624K$633K$503K$4M$0
Total Non-Current Assets$3M$3M$3M$5M$3M
Total Assets$57M$26M$9M$11M$8M
— Liabilities —
Accounts Payable$12M$8M$6M$6M$6M
Short-Term Debt$5M$2M$17M$13M$4M
Deferred Revenue$37K$0$0$0$396K
Other Current Liabilities$3M$789K$488K$459K$3M
Total Current Liabilities$22M$15M$25M$23M$13M
Long-Term Debt$6M$14M$5M$5M$9M
Other Non-Current Liab.$11M$11M$8M$10M$7M
Total Non-Current Liabilities$18M$27M$15M$15M$21M
Total Liabilities$41M$41M$40M$38M$33M
— Equity —
Common Stock$1M$1M$2M$3M$6M
Retained Earnings-$29M-$28M-$26M-$14M$0
Accumulated OCI-$138M-$170M-$197M-$223M-$236M
Total Stockholders Equity$16M-$15M-$31M-$27M-$25M
Total Liabilities & Equity$57M$26M$9M$11M$8M
— Key Metrics —
Total Debt$13M$18M$24M$19M$13M
Net Debt-$32M$7M$21M$17M$10M
Total Investments$0$633K$0$0$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms